Pathway
Loss of Function of KMT2D in Kabuki Syndrome
Loss of function mutations in histone-lysine-N-methyltransferase (KMT2D), an epigenetic modifier associated with active transcription, is the major cause of Kabuki syndrome, a rare disorder that affects 1 in 32,000 births. Kabuki syndrome is characterized by distinct facial features such as long palpebral fissures with eversion of the lateral third of the lower eyelid and short columella with depressed nasal tip, skeletal anomalies, intellectual disability, and postnatal growth deficiency. Besides Kabuki syndrome, germline mutations in KMT2D are associated with another rare multiple malformation syndrome characterized by branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism. Functionally characterized KMT2D mutations, as well as mutations occuring in the same residues, are annotated.
Continue reading
The pathway “Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome” describes KMT2D loss-of-function mutations reported in Kabuki syndrome that impair its ability to bind the WRAD complex.
What the reference databases state
Statements
5 statements
5 statements · 1 reference database · Subject: Loss of Function of KMT2D in Kabuki Syndrome · Sources: Reactome
- ASH2L participates in Loss of Function of KMT2D in Kabuki SyndromeProteinReactome R-HSA-9944971Inferred only
- DPY30 participates in Loss of Function of KMT2D in Kabuki SyndromeProteinReactome R-HSA-9944971Inferred only
- KMT2D participates in Loss of Function of KMT2D in Kabuki SyndromeProteinReactome R-HSA-9944971Inferred only
- RBBP5 participates in Loss of Function of KMT2D in Kabuki SyndromeProteinReactome R-HSA-9944971Inferred only
- WDR5 participates in Loss of Function of KMT2D in Kabuki SyndromeProteinReactome R-HSA-9944971Inferred only